Sample | Concentration (mg/ml) | Time (min) | |
---|---|---|---|
Paralysis time | Death time | ||
Standard (albendazaole) | 10 | 35.40 ± 0.51 | 73.40 ± 1.21 |
20 | 20.80 ± 1.28 | 54.00 ± 1.45 | |
CSF | 10 | 17.80 ± .58*** | 30.80 ± 1.11*** |
20 | 11.80 ± 1.02** | 22.00 ± 1.00*** | |
ASF | 10 | 87.60 ± 0.51*** | 99.40 ± 0.81*** |
20 | 54.40 ± 1.29*** | 67.60 ± 2.42** | |
MCE | 10 | 53.60 ± 0.81*** | 62.20 ± 0.97** |
20 | 33.80 ± 1.24** | 47.40 ± 1.57** | |
n-HSF | 10 | 13.20 ± 0.58*** | 22.40 ± 1.36*** |
20 | 8.80 ± 0.97** | 15.60 ± 1.08*** | |
Control (1% CMC in normal saline) | – | – | – |